GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Entia Biosciences Inc (OTCPK:ERGO) » Definitions » 12-1 Month Momentum %

Entia Biosciences (Entia Biosciences) 12-1 Month Momentum % : -50.00% (As of May. 04, 2024)


View and export this data going back to 2007. Start your Free Trial

What is Entia Biosciences 12-1 Month Momentum %?

12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2024-05-04), Entia Biosciences's 12-1 Month Momentum % is -50.00%.

The industry rank for Entia Biosciences's 12-1 Month Momentum % or its related term are showing as below:

ERGO's 12-1 Month Momentum % is not ranked
in the Biotechnology industry.
Industry Median: -21.305 vs ERGO: -50.00

Competitive Comparison of Entia Biosciences's 12-1 Month Momentum %

For the Biotechnology subindustry, Entia Biosciences's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Entia Biosciences's 12-1 Month Momentum % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Entia Biosciences's 12-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Entia Biosciences's 12-1 Month Momentum % falls into.



Entia Biosciences  (OTCPK:ERGO) 12-1 Month Momentum % Calculation

12-1 Month Momentum % is calculated as following:

12-1 Month Momentum %=( Price 1-month ago / Price 12-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Entia Biosciences  (OTCPK:ERGO) 12-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Entia Biosciences 12-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Entia Biosciences's 12-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Entia Biosciences (Entia Biosciences) Business Description

Traded in Other Exchanges
N/A
Address
13565 South West Tualatin-Sherwood Road, Suite 800, Sherwood, OR, USA, 97140
Entia Biosciences Inc operates as a biotechnology company, is engaged in the development, production, and distribution of dietary supplements, nutraceuticals, and medical foods products, principally in the United States of America. It market nutraceutical products under the name GROH and SANO directly to the consumers online. It currently offers natural organic nutraceutical mushroom dietary supplement products, ImmuSANO, GlucoSANO, and GROH, which has been designed to nutritionally support hair follicles and nail beds. It derives its revenue from the sale of its GROH line and mushroom-based nutraceutical dietary supplement products and functional ingredients.
Executives
Carl J Johnson director, officer: President and CEO
Hausman Marvin S Md director, officer: Chairman, CSTO 825 THIRD AVE, 40TH FL, NEW YORK NY 10022
Anka Capital Ltd 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTRE, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -
Cheuk Ho Tam 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTER, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -
Wah On Wong 10 percent owner ROOM 2204 22F WEST TOWER SHUN TAK CENTER, 200 CONNAUGHT ROAD CENTRAL, SHEUNG WAN K3 -

Entia Biosciences (Entia Biosciences) Headlines